Eastman Chemical Reports Significant Q4 & Full-Year 2025 Earnings Decline; Withholds Full-Year 2026 Guidance
summarizeSummary
Eastman Chemical reported a significant year-over-year decline in Q4 and full-year 2025 earnings and sales, citing a challenging market. The company withheld full-year 2026 EPS guidance due to macroeconomic uncertainty, though it provided Q1 2026 guidance and announced increased cost reduction initiatives.
check_boxKey Events
-
Q4 2025 Adjusted EPS Misses
Adjusted earnings per diluted share for Q4 2025 were $0.75, a 60% decrease compared to $1.87 in Q4 2024.
-
Full-Year 2025 Adjusted EPS Decline
Full-year 2025 adjusted earnings per diluted share were $5.42, down 31% from $7.89 in 2024.
-
No Full-Year 2026 EPS Guidance
The company did not provide full-year 2026 adjusted EPS guidance, citing 'significant macroeconomic uncertainty'.
-
Q1 2026 Adjusted EPS Guidance Provided
Eastman expects Q1 2026 adjusted EPS to be between $1.00 and $1.20, excluding the impact of winter storms.
auto_awesomeAnalysis
Eastman Chemical Company reported a substantial decline in its fourth-quarter and full-year 2025 financial results, with adjusted earnings per share falling 60% in Q4 and 31% for the full year compared to 2024. Sales revenue also decreased significantly. The company attributed the weakness to a challenging operating environment, including lower sales volume/mix, customer inventory destocking, and weak consumer discretionary end markets. A key concern for investors is the decision to withhold full-year 2026 adjusted EPS guidance due to 'significant macroeconomic uncertainty,' signaling a lack of clear visibility. While management expects to 'meaningfully improve earnings' in 2026 and has increased cost reduction targets to $125 million-$150 million, the absence of specific full-year guidance, coupled with the poor 2025 performance, creates considerable uncertainty. The Q1 2026 adjusted EPS guidance of $1.00-$1.20, while a sequential improvement from Q4 2025, remains well below prior year levels.
At the time of this filing, EMN was trading at $67.26 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.9B. The 52-week trading range was $56.11 to $103.82. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.